Cargando…
Montelukast and budesonide combination for children with chronic cough-variant asthma
This study investigated the effectiveness and safety of montelukast combined budesonide (MCB) treatment for children with chronic cough-variant asthma (CCVA). In total, 82 cases of children with CCVA, aged 4 to 11 years were included in this study. All cases received either MCB or budesonide alone b...
Autores principales: | Wang, Xiu-ping, Yang, Lin-dong, Zhou, Jin-fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078752/ https://www.ncbi.nlm.nih.gov/pubmed/30045280 http://dx.doi.org/10.1097/MD.0000000000011557 |
Ejemplares similares
-
Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma
por: Yi, Fang, et al.
Publicado: (2022) -
Clinical efficacy of montelukast sodium combined with budesonide or combined with loratadine in treating children with cough variant asthma and influence on inflammatory factors in the serum
por: Wei, Haiyan, et al.
Publicado: (2019) -
Evaluation of efficiency and safety of combined montelukast sodium and budesonide in children with cough variant asthma: A protocol for systematic review and meta-analysis
por: Tang, Qiongyao, et al.
Publicado: (2021) -
Budesonide/Fomoterol in combination with Montelukast in the treatment of Bronchial Asthma
por: Dai, Xiaoxia, et al.
Publicado: (2020) -
A multicenter, prospective, observational study on montelukast monotherapy or montelukast-based combinations treating cough variant asthma
por: Lin, Jiangtao, et al.
Publicado: (2020)